Dr. Kevin Zorn, MD, FRCSC, FACS, Urologist, discusses BPH and the Cystoscopy procedure. Donald Trump reacts to Iran's strike on US base Map shows states where risk of dementia is highest—are you ...

The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).

Drs. Indraneel Banerjee and John S. Banerji, urologists at Penn Highlands Urology in DuBois, have reached a significant ...

OSLO, Norway, April 29, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces four abstract presentations at the AUA 2025, highlighting the benefits of Blue Light ...

Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

Consequently, when using Blue Light Cystoscopy with Cysview, bladder cancer management decisions can be made more appropriately. The poster presentation (Abstract No. 686, ...

OSLO, Norway, Feb. 17, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S ...

A cystoscopy, also known as a bladder scope, is a medical test used to check for diseases of the bladder and urethra. Learn more about the purpose and risks of this procedure.